# OnCo record epirubicin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/epirubicin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "epirubicin" ;
  schema:name "Epirubicin"@en ;
  schema:alternateName "Pharmorubicin"@en, "Ellence" ;
  schema:description "Epirubicin (Ellence) is a close relative of doxorubicin used mainly after breast cancer surgery when lymph nodes are involved, and in stomach cancer regimens; it is a little kinder to the heart."@en ;
  schema:url <https://onco.cc/drugs/epirubicin/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Epirubicin> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=epirubicin>, <https://www.cancer.gov/about-cancer/treatment/drugs/epirubicinhydrochloride> ;
  onco:status "approved" ;
  onco:tag "nci-list", "generic" ;
  onco:modality "Anthracycline (topoisomerase II inhibitor)" ;
  onco:approval "US 1999: Adjuvant therapy for axillary node-positive breast cancer" ;
  onco:related <https://onco.cc/drugs/doxorubicin/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/gastric/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:companies <https://onco.cc/companies/pfizer/> ;
  onco:trials <https://onco.cc/trials/nct03725059/>, <https://onco.cc/trials/nct06227117/>, <https://onco.cc/trials/nct06389006/>, <https://onco.cc/trials/nct06966700/>, <https://onco.cc/trials/nct06797635/>, <https://onco.cc/trials/nct06112379/> .